유전자 발현 시장 규모, 점유율, 성장 분석 : 기술별, 제품별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Gene Expression Market size was valued at USD 4.82 Billion in 2024 and is poised to grow from USD 5.2 Billion in 2025 to USD 9.52 Billion by 2033, growing at a CAGR of 7.88% during the forecast period (2026-2033).

The gene expression market is witnessing robust growth, driven by the rising demand for precision medicine and increased adoption of transcriptomics research. Investments in genomics and biotechnology, along with advancements in sequencing technologies, are key factors propelling market expansion. There is a surge in high-throughput transcriptomic technologies and sophisticated molecular research tools, particularly in fields such as oncology, infectious diseases, and pharmaceutical R&D. The integration of artificial intelligence further enhances gene expression analysis, facilitating the identification of disease biomarkers and improving targeted therapies. Automated sequencing in clinical laboratories streamlines diagnostic processes, while cloud-based informatics tools and data analytics promote innovation and collaboration. However, high costs and complexities in data interpretation, along with regulatory challenges, may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Expression market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Expression Market Segments Analysis

Global gene expression market is segmented by technology, product, application, end-user, and region. Based on technology, the market is segmented into Microarrays, qPCR, Next-Generation Sequencing (RNA-seq), Northern Blotting, and Single-Cell RNA-seq. Based on product, the market is segmented into instruments, reagents & consumables, and software. Based on application, the market is segmented into drug discovery, biomarker research, disease diagnosis, and agricultural research. Based on end-user, the market is segmented into pharma & biotech, research institutes, CROs, and hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Gene Expression Market

The Global Gene Expression market is significantly driven by advancements in sequencing technologies and other related platforms. Enhanced sensitivity and throughput, coupled with improved usability, have facilitated the execution of comprehensive gene expression studies, making them more accessible for researchers and clinicians alike. As these technologies evolve, they allow for the exploration of intricate biological questions and the detection of subtle expression variations. This growing accessibility fosters expansion into new application areas, leading to heightened demand for reagents, equipment, and support services. Furthermore, as these platforms become integral to data analysis and research workflows, investments in related products and services increase, promoting efficiency and broader commercial options.

Restraints in the Global Gene Expression Market

The high costs associated with acquiring and sustaining advanced gene expression platforms and reagents pose a significant obstacle for smaller institutions. These substantial financial commitments can hinder the adoption of innovative technologies, potentially leading to slower market penetration and development. As a result, many organizations may opt to continue using established systems or turn to outsourcing rather than investing in new solutions. This reluctance to adopt cutting-edge technologies, driven by financial constraints, creates a restraining effect on the global gene expression market until more affordable options become available, limiting progress and innovation within the industry.

Market Trends of the Global Gene Expression Market

The Global Gene Expression market is witnessing a significant trend towards the expansion of single-cell profiling, driven by the increasing demand for enhanced gene expression methodologies. The need for detailed insights into cellular diversity in both fundamental research and translational applications is propelling investments in advanced instrumentation, assay components, and sophisticated informatics tools. This market trend is characterized by collaborative partnerships among instrument developers and software providers, aimed at creating integrated processing pipelines. These collaborations enhance discovery in heterogeneous tissues and facilitate streamlined translational studies by effectively integrating expression data across diverse cell types and microenvironments, ultimately advancing biological research and therapeutic development.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Gene Expression Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Microarrays
• qPCR
• Next-Generation Sequencing (RNA-seq)
• Northern Blotting
• Single-Cell RNA-seq

Global Gene Expression Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Consumables
• Software

Global Gene Expression Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Biomarker Research
• Disease Diagnosis
• Agricultural Research

Global Gene Expression Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharma & Biotech
• Research Institutes
• CROs
• Hospitals

Global Gene Expression Market Size & CAGR (2026-2033)

• North America (Technology, Product, Application, End-User)
  • US
  • Canada
• Europe (Technology, Product, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix (Thermo Fisher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lexogen GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations